# KHFM HOSPITALIT (NSE: KHFM) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/KHFM · Pivot · prices to 15 Oct 2026

KHFM HOSPITALIT (NSE: KHFM) closed at ₹40.90 on 15 Oct 2026. With a market capitalisation of ₹95 Cr, it ranks 2700th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector.

Its return on equity was 5.2% in FY26. Over the past year the share price has fallen 50.1%. Its 52-week range is ₹39.00 (14 Oct 2026) to ₹82.95 (28 Oct 2025); the last close is 50.7% below the high. Promoters held 37.17% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹40.90 |
| Market cap | ₹95 Cr |
| ROE | 5.2% (FY26) |
| ROCE | 13.3% (FY26) |
| Debt to equity | 0.52 |
| 52-week high | ₹82.95 (28 Oct 2025) |
| 52-week low | ₹39.00 (14 Oct 2026) |
| 1-year return | −50.1% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹107 Cr | ₹3 Cr |
| FY25 | ₹104 Cr | ₹3 Cr |
| FY24 | ₹112 Cr | ₹3 Cr |
| FY23 | ₹90 Cr | ₹3 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 37.17%
- Non-institutions: 62.83%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Mercury Labs](https://app.pivotnow.in/stock/MERCURYLAB) | — | ₹102 Cr | — | — |
| [Vaishali Pharma](https://app.pivotnow.in/stock/VAISHALI) | ₹7.49 | ₹101 Cr | 124.8 | — |
| [Concord Drugs](https://app.pivotnow.in/stock/CONCORD) | — | ₹101 Cr | — | — |
| [Denis Chem Lab](https://app.pivotnow.in/stock/DENISCHEM) | — | ₹101 Cr | — | — |
| [Fortis Malar](https://app.pivotnow.in/stock/FORTISMLR) | — | ₹97 Cr | — | — |
| [Raaj Medisafe](https://app.pivotnow.in/stock/RAAJMEDI) | — | ₹97 Cr | — | — |

## Questions and answers

### What is the share price of KHFM HOSPITALIT today?

KHFM HOSPITALIT (NSE: KHFM) last closed at ₹40.90 on 15 Oct 2026. Its 52-week high is ₹82.95 and its 52-week low is ₹39.00.

### What is the market cap of KHFM HOSPITALIT?

KHFM HOSPITALIT's market capitalisation is ₹95 Cr (₹95 Cr) at the 22 Oct 2026 close, ranking 2700th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of KHFM HOSPITALIT?

Return on equity was 5.2% in FY26 and return on capital employed was 13.3% in FY26 (consolidated figures).

### Is KHFM HOSPITALIT a debt-free company?

No. KHFM HOSPITALIT's debt-to-equity ratio was 0.52 in FY26, with total debt of ₹0 Cr.

### How has KHFM HOSPITALIT stock performed over the last year?

KHFM HOSPITALIT's share price has fallen 50.1% over the past year, −36.0% over three months and −9.0% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of KHFM HOSPITALIT?

As of 31 Mar 2026: promoters 37.17%, non-institutions 62.83%.

### Who are KHFM HOSPITALIT's competitors?

The listed Pharma & Healthcare companies closest to KHFM HOSPITALIT by market cap are Mercury Labs, Vaishali Pharma, Concord Drugs, Denis Chem Lab, Fortis Malar and Raaj Medisafe.

### Is KHFM HOSPITALIT a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out KHFM HOSPITALIT's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KHFM against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.